TrialBritish journal of haematology2020

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia.

Malin S Nilsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.